“…This month's lead article by Aznar et al addresses this question. 4 They conducted a single center retrospective analysis of 658 endometrial cancer patients categorized by molecular classification. Among them, 122 (18.5%) experienced relapses, which were categorized by site of recurrence into vaginal, pelvic, peritoneal, nodal, and distant.…”